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Abstract
Hemorrhagic shock is a frequent cause of liver failure and often leads to a fatal outcome. Several studies have revealed that
p38 MAPK is a key mediator in hemorrhagic damage of the primary organs through the activation of proinflammatory
cytokines such as tumor necrosis factor (TNF)-a and interleukin (IL)-1b. However, the precise role of these factors in liver
damage following hemorrhagic shock is unclear. In this study, we used FR167653, a specific inhibitor of p38 MAPK
phosphorylation, to examine the role of p38 MAPK in liver damage occurring up to 5 hours after a hemorrhagic episode in a
rat model. Activation of p38 MAPK in the liver as well as an increase in hepatic mRNA expression and serum concentrations
of TNF-a and IL-1b occurred during the early phase after hemorrhage. Increased serum levels of hepatic enzymes, as well as
histological damage and activated neutrophil accumulation in the liver, were observed in the late phase following
hemorrhagic shock. FR167653 inhibited the inflammation-related hepatic injury following hemorrhagic shock. Bacterial
lipopolysaccharide (LPS) derived from the gut appeared to have little effects on the hepatic damage. These results
demonstrate that p38 MAPK activation is induced by hepatic ischemia during hemorrhagic shock and plays an important
role both in the hepatic expression of proinflammatory cytokines and in the development of inflammation-related liver
damage.
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Introduction
The liver, which plays a crucial role in metabolism and
homeostasis, is one of the organs that is most susceptible to injury
arising from hemorrhagic shock, the outcome of which is often
fatal [1]. Several studies on ischemic-reperfusion injury of the liver
have suggested that p38 MAPK plays a pivotal role in the
progression of hemorrhage-induced damage [2,3,4,5,6]. p38
MAPK has been postulated to be one of the key factors promoting
the expression of pro-inflammatory cytokines such as TNF-a and
IL-1b [7]. These cytokines play an important role in inflammatory
organ damage by promoting the recruitment of neutrophils which
release reactive oxygen species and proteases [8,9,10]. Ischemia
and ischemia-reperfusion of organs are consequences of systemic
hemodynamic changes following hemorrhagic shock
[10,11,12,13]. We previously hypothesized that p38 MAPK
activation might play an important role in the progression of liver
damage following hemorrhagic shock, but this possibility was not
tested experimentally.
In this study, the role of p38 MAPK activation in the
development of inflammatory liver damage following hemorrhagic
shock was examined by the use of FR167653, which is a specific
inhibitor of p38 MAPK phosphorylation. Our experimental model
provided a novel paradigm to explore the cause of liver damage
following hemorrhagic shock.
Materials and Methods
Animals
Male Wistar rats (Seiwa Experimental Animal Co.; Oita, Japan)
weighing 260 g to 350 g were used. The rats were allowed to
acclimate and were maintained at 22uC with 12 hours light-dark
cycles for 2 weeks with ad libitum access to water and standard rat
feed. The animals were fasted overnight (with ad libitum access to
water) prior to the experiments so as to minimize the possible
influence of feeding on factors such as the vomiting reflex,
hemodynamic responses, and other unexpected reactions. The
Ethics Committee of Animal Care and Experimentation, Univer-
sity of Occupational and Environmental Health, Japan, approved
all requests for animals and the intended procedures of the present
study (Permission numbers: AE 07-029) according to the Guide for
the Care and Use of Laboratory Animals published by the US
National Institute of Health (NIH Publication No 85-23, revised
1996).
Hemorrhage procedure
Animals were anesthetized using a mixture of urethane (ethyl
carbamate; 470 mg/kg body weight) and a-chloralose (23 mg/kg
body weight) administered by intraperitoneal injection with
touchup dosing as needed to maintain a sufficient depth of
anesthesia throughout the experimental period. The animals were
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board (3761uC) and allowed to breathe spontaneously. After the
induction of anesthesia, the left femoral artery was cannulated
under aseptic conditions with a 3 Fr polyethylene catheter (Atom
Medical Co., Tokyo, Japan) connected to a blood pressure
transducer (G-1000, Nihon Kohden, Tokyo, Japan) and a
polygraph (LEG-1000, Nihon Kohden, Tokyo, Japan) for blood
pressure monitoring. Heparinized saline (700 U/ml) was used to
fill the cannula prior to placement and to prevent systemic
coagulation after placement. The hepatic artery was exposed via a
midline laparotomy and a flow probe with LBF–III laser Doppler
flow meter (Biomedical Science, Kanazawa, Japan) was placed on
the artery. Hepatic arterial blood flow (HBF) and mean arterial
blood pressure (MBP) were measured every 20 minutes. The HBF
values of the controls (Sham group) were expressed as a ratio
relative to the average values at time 0, and those of the
hemorrhage groups were expressed as a ratio relative to the
average values of the Sham group at each timepoint. After an
equilibrium period, the rats were bled via the catheter using a
syringe at a constant rate for 20 minutes. Up to 25% (i.e.
1.625 ml/100 g) of the total body blood volume (6.560.1ml/
100 g body weight) [14] was drawn.
Prior to conducting the main experiment, we investigated the
effect of bleeding volume on the 5-hour-mortality rate. Following
bleeding of 33% of the total blood volume, the mortality rate was
50%; failure of the cardiovascular system occurred promptly and
was followed immediately by death or a near-death state while
under anesthesia. With bleeding of up to 25% of the total blood
volume, few animals died but most suffered from hemorrhagic
shock during the first 5 hours under anesthesia. To maximize
experimental reproducibility and stability, 25% bleeding was
employed in all subsequent experiments.
Many studies have investigated hemorrhagic shock using
artificial continuous long-term hypotension and fluid resuscitation
models [15,16]. Tsukamoto et al. reported that fixed-pressure
hemorrhage models were reproducible but did not correspond
with clinical cases in which the shock episode was not sustained for
a sufficiently long duration as a result of various autoregulatory
reactions, such as tachycardia, vasoconstriction, oliguria, and
absorption of interstitial fluid into the blood [17]. Therefore, in
this study, we used a bleeding model rather that the artificial
sustained hypotension and fluid re-infusion model for investigating
the intrinsic pathophysiological processes following hemorrhagic
shock.
Experimental protocol
Rats were divided into 4 treatment groups. Non-bled rats
treated with physiological saline served as negative controls (Sham
group), while rats that underwent hemorrhage and were treated
with saline served as positive controls (Hemorrhage group). In
addition, to determine whether p38 MAPK activation affects the
inflammatory hepatic injury following hemorrhagic shock, rats
treated with FR167653 (FR) were subjected to sham (FR group) or
hemorrhage (FR+Hemorrhage group) procedures. After recording
MBP and HBF, the rats in each group were sacrificed by
exsanguination from punctured hepatic and portal veins, and the
livers were collected at 1, 3 or 5 hours after bleeding (n=5 in each
group except in the MAPK assay). Serum was separated by
centrifuging the blood samples, collected from the hepatic and
portal veins, at 3,000 rpm for 20 minutes. The tissue and serum
samples were stored at –80uC until assayed.
FR, {1-[7-(4-fluorophenyl)-1,2,3,4-tetrahydro-8-(4-pyridyl)pyra-
zolo[5,1-c](1,2,4) triazin–2-yl]-2-phenylethanedine sulfate mono-
hydrate}(Astellas Pharma Inc., Tokyo, Japan), is a novel synthetic
compound that prevents p38 MAPK activation by suppressing p38
MAPK phosphorylation [4,18]. FR has frequently been used to
study the role of p38 MAPK activation [4,5,19,20]. FR was
dissolved in physiological saline at a concentration of 5 mg/ml and
administered at a dose of 5 mg/kg body weight. Several studies
have reported the use of FR167653 at doses of 1 to 10 mg/kg
body weight without causing liver damage as a side effect [4,5,20].
FR or physiological saline was administered by intramuscular
injection in the anterior region of the right thigh 30 minutes after
the cannulation, and bleeding was started 30 minutes after
intramuscular injection.
Bacterial LPS concentration in the portal vein
Whole blood samples collected from the portal vein were
centrifuged at 3,000 rpm for 10 minutes, and the separated
plasma was used for the assay. The high-sensitivity analysis was
carried out by kinetic turbidimetric Limulus assay using a MT-251
Toxinometer (Wako, Osaka, Japan), which theoretically can
measure LPS at concentrations as low as 0.01pg/mL.
Assessment of p38 MAPK activation in the liver
Western blot analysis was performed as described previously
[12,13]. Briefly, liver tissue was homogenized with extraction
buffer (10 mM Tris, pH 8.0, 5 mM EDTA, 50 mM NaCl,
30 mM sodium pyrophosphate, 50 mM sodium fluoride, and
100 mM sodium vanadate) containing protease inhibitors cocktail.
After centrifugation at 18,000xg for 20 minutes, the protein
concentration in the upper layer was measured; 20 mg of the lysate
was then resolved by SDS-PAGE and transferred to PVDF
membranes (Immobilon, Millipore Corp, Bedford, MA, USA).
The membrane was blocked with TBS buffer (10 mM Tris-Cl,
pH 7.4, 0.15 M NaCl) containing 5% nonfat dried milk, then
reacted with rabbit polyclonal phospho-p38 MAPK antibody or
rabbit polyclonal p38 MAPK antibody (1:1000 dilution; New
England Biolabs, Beverly, MA, USA) at 4uC for 16 hours. After
incubation with goat anti-rabbit IgG peroxidase conjugate (1:1000
dilution; DAKO, Glostrup, Denmark) for 1 hour at 25uC, the
immune complex was visualized using enhanced chemilumines-
cence (Amersham Bioscience, Piscataway, NJ, USA). The densities
of the bands were quantified using Scion Image Beta 4.02 (Scion
Corporation, Frederick, MA, USA) and the ratio of phospholyl/
non-phospholyl p38 MAPK was calculated. The values were
expressed as a ratio relative to the average value for the Sham
group at each timepoint.
Assessment of TNF-a and IL-1b mRNA expression in the
liver
Total RNA was extracted from each liver using ISOGEN
(Nippon gene, Toyama, Japan). A 1 mg aliquot of total RNA from
liver was reverse-transcribed using RNase H-reverse Transcription
and random hexamers (Invitrogen, CA, USA). To assess the
amount of TNF-a and IL-1b mRNA in each sample, polymerized
chain reaction (PCR) was performed for TNF-a, IL-1band
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), the latter
being a constitutively expressed housekeeping gene. PCR was
performed in 5.0 mL of PCR sample using the AmplitTaq Gold
360 Master Mix (Applied Biosytems, CA, USA). PCR products
were separated by electrophoresis using 1% agarose gel containing
0.3 mg/ml ethidium bromide to visualize DNA bands, and the gels
were scanned using a Mupid-Scope WD (Advance, Tokyo, Japan).
Densitometry was performed with Adobe Photoshop software
(Adobe Systems Inc, Mountain View, CA, USA). The densities of
the bands were quantified using Scion Image Beta 4.02 (Scion
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GAPDH mRNA was calculated. The values were expressed as a
ratio as described above for p38 MAPK activation.
Hepatic serum TNF-a and IL-1b concentration
The concentrations of TNF-a and IL-1b in serum collected
from the hepatic vein were measured using rat TNF-a and IL-1b
enzyme linked immunosorbant assay kits (Invitrogen, CA, USA).
Liver enzymes analysis
The serum levels of aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) were measured to assess damage
to the hepatic parenchyma. Blood samples were processed in a
Hitachi 7350 automatic analyzer (Hitachi Ltd., Tokyo, Japan) and
enzyme levels were expressed as units per liter.
Histological examination
For light microscopic examination, the right lobe of the liver
was cut into 2-mm-thick slices and fixed with 2.5% glutaraldehyde
in 0.1 M phosphate-buffered saline (PBS), pH 7.6. Dewaxed
sections were incubated in 3% hydrogen peroxide for 10 min and
washed in 0.1 M PBS, pH 7.6. Rabbit polyclonal anti-rat
myeloperoxidase (MPO) antibody as a marker for neutrophils
(Laboratory Vision Co., CA, USA) was applied to the sections,
which were then incubated at room temperature for 1 hour.
Products resulting from the immunoreaction were visualized by
the peroxidase-conjugated streptavidin-biotin method (Simple-
Stain-PO kit; Nichirei Corp. Tokyo, Japan) using 3,39-diamino-
benzidine tetrahydrochloride (DAB) and hydrogen peroxide. The
nuclei were counterstained with hematoxylin. As a control for
immunostaining, Tris buffer or normal sera were substituted for
the primary antibodies.
Histological changes were assessed and MPO-positive cells were
counted in 10 randomly selected fields per liver (500 mm
2) for 5
rats in each group. The MPO data were expressed as the number
of positive cells per field. All histological analyses were performed
by a pathologist without prior knowledge of the experimental
conditions.
Statistical analysis
Data are expressed as mean6SE. Differences among groups
were tested for statistical significance using one-way analysis of
variance and Fisher post hoc testing. Data correlations were tested
using Pearson’s correlation coefficient test. A p value of less than
0.05 was regarded as a statistically significant difference.
Results
Changes in systemic blood pressure and hepatic blood
flow caused by hemorrhage
There were no significant differences in MBP between the
Sham group and FR group throughout the experiment (Fig. 1A,
Fig. 1C). MBP significantly decreased immediately after a
hemorrhage as shown in Fig. 1B and Fig. 1D, (from 102
66 mmHg to 4163 mmHg in the Hemorrhage group; from
11068 mmHg to 4364 mmHg in the FR+Hemorrhage group)
and returned to the baseline level at 40 minutes after hemorrhage
in both groups. In the latter phase after hemorrhage, MBP tended
to decrease gradually over time and was significantly lower in the
Hemorrhage group than in the Sham group at 240 minutes
(Fig. 1B), although MBP in the FR+Hemorrhage group did not
show a decrease in MBP during the latter phase after hemorrhage
(Fig. 1D).
Similarly, HBF in the hemorrhage groups decreased after
hemorrhage as shown in Fig. 2B and Fig. 2D, (from 1.0160.03 to
0.4360.03 in the Hemorrhage group; from 1.0160.03 to
0.4760.05 in the FR+Hemorrhage group), and like MBP, HBF
recovered thereafter (Fig. 2B, 2D). In the latter phase after
hemorrhage, HBF decreased gradually again in the Hemorrhage
group (Fig. 2B), but did not show such a decrease in the
FR+Hemorrhage group (Fig. 2D).
Figure 1. Time course of mean arterial blood pressure (MBP).
Hemorrhage was induced for 20 minutes (shaded area). A: Sham group
(Sham), B: Hemorrhage group (Hemorrhage), C: Sham with FR167653
treatment (FR), D: Hemorrhage with FR167653 treatment (FR+Hemor-
rhage). MBP decreased significantly just after hemorrhage and returned
to baseline at 40 minutes, but decreased gradually in the latter phase in
the Hemorrhage group (B). FR treatment did not have any effect on the
primary MBP decrease, although it abolished the secondary MBP
decrease after hemorrhage (D). Data are shown as mean6SE. n=5/
groups, * p,0.05 vs Sham, + p,0.05 between Hemorrhage and
FR+Hemorrhage.
doi:10.1371/journal.pone.0030124.g001
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There were no significant increases in the portal vein LPS
concentration in any of the groups throughout the experimental
period as shown in Fig. 3. The portal vein LPS concentration in
the Hemorrhage group appeared to increase slightly at 1hour after
hemorrhage (25.0611.1 pg/ml) but did not differ significantly
relative to the Sham group (12.863.9 pg/ml) throughout the
experiment.
Assessment of p38 MAPK activation in the liver
The p38 MAPK phosphorylation level was 1.7660.34 at 1hour
after hemorrhage in the Hemorrhage group, which was signifi-
cantly higher than in the Sham group, as shown in Fig. 4.
Phosphorylation returned to baseline levels at 3 hours after
hemorrhage. The phosphorylation of p38 MAPK induced by
hemorrhagic shock was inhibited in the FR+Hemorrhage group at
1hour after hemorrhage (1.0360.12). There were no significant
differences from baseline in the p38 MAPK phosphorylation
Figure 2. Time course of hepatic arterial blood flow (HBF). The
abbreviations are the same as those in Fig. 1. The change in HBF was
similar to that in MBP. Data are shown as mean6SE. n=5/groups,
*p ,0.05 vs Sham, + p,0.05 between Hemorrhage and FR+Hemor-
rhage.
doi:10.1371/journal.pone.0030124.g002
Figure 3. Bacterial LPS concentration in the portal vein. There
were no significant increases in the portal LPS concentration in any of
the groups throughout the experimental period. Data are shown as
mean6SE. n=5/groups.
doi:10.1371/journal.pone.0030124.g003
Figure 4. Changes in hepatic p38 MAPK activation after
hemorrhage. The activation of p38 MAPK was assessed by Western
blotting analysis. p38 MAPK phosphorylation levels, shown on the
vertical axis in B, were determined after normalization using the density
ratio of the phosphorylated p38 MAPK band (p-p38 MAPK in A) divided
by the p38 MAPK band (p38 MAPK in A). Activation of p38 MAPK was
significantly higher at 1 hour and returned to the baseline level at
3 hours after hemorrhage. Activation of p38 MAPK activation in the
FR+Hemorrhage group did not change significantly at any time after a
hemorrhage. Data are shown as mean6SE. n=5/groups, * p,0.05 vs
Sham, + p,0.05 between Hemorrhage and FR+Hemorrhage.
doi:10.1371/journal.pone.0030124.g004
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experiment.
TNF-a mRNA expression in the liver and serum TNF-a
concentration
TNF-a mRNA expression in the Hemorrhage group peaked at
1 hour after hemorrhage and was significantly higher than in the
Sham group at all times after hemorrhage (3.5060.55 at 1 hour,
2.4060.46 at 3 hours, 1.7560.2 at 5 hours). No increase in TNF-
a mRNA expression levels occurred in the FR+Hemorrhage
group at any timepoint after hemorrhage (Fig. 5A, Fig. 5B).
The concentration of serum TNF-a is shown in Fig. 5C. The
serum TNF-a concentration in the Hemorrhage group was highest
at 1 hour after hemorrhage and was significantly higher than in
the Sham group at all timepoints (90.569.3 pg/ml at 1 hour,
62.069.1 pg/ml at 3 hours, 35.563.0 pg/ml at 5 hours). The
post-hemorrhage increase in serum TNF-a levels was inhibited in
the FR+Hemorrhage group at all timepoints (Fig. 5C).
IL-1b mRNA expression in the liver and serum IL-1b
concentration
IL-1b mRNA expression in the liver was highest at 3 hours after
hemorrhage and was significantly higher than in the Sham group
at all timepoints (2.8060.34 at 1 hour, 3.7060.58 at 3 hours,
3.260.33 at 5 hours). The post-hemorrhage increase in IL-
1bmRNA expression levels was suppressed in the FR+Hemor-
rhage group at all timepoints (Fig. 6A, Fig. 6B).
The serum IL-1bconcentration was also highest at 3 hours after
hemorrhage and was significantly higher than in the Sham group
at all timepoints (62.9611.9pg/ml at 1 hour, 97.6619.7 at
3 hours, 82.4610.7 at 5 hours). The post-hemorrhage increase in
serum IL-1b levels was suppressed in the FR+Hemorrhage group
at all timepoints (Fig. 6C).
Liver enzymes analysis
The serum AST level in the Hemorrhage group increased with
time and was significantly higher than in the Sham group at
5 hours after hemorrhage (39.664.2 IU/l at 1 hour, 44.663.8
IU/l at 3 hours, 65.666.2 IU/l at 5 hours). In contrast with the
Hemorrhage group, the FR+ Hemorrhage group did not show any
significant changes in serum AST levels at any timepoint (Fig. 7A).
Changes in the serum levels of ALT were similar to those of AST
(Fig. 7B). The serum ALT level in the Hemorrhage group
increased over time and was significantly higher than the Sham
group at 5 hours after hemorrhage (37.463.1 IU/l at 1 hour,
44.066.5 IU/l at 3 hours, 56.868.2 IU/l at 5 hours). There were
no significant changes in the serum levels of AST or ALT in the
Sham group or FR groups throughout the experimental period.
Histological examination
In the Hemorrhage group, the interstitial space was edematous
and the sinusoidal capillaries were dilated with diffuse congestion.
A clustered appearance of reddish brown precipitates in the
sinusoidal cavity or interstitial space indicated the presence of
activated neutrophils (Fig. 8A). These changes were seldom
observed in the FR+Hemorrhage group (Fig. 8B). The number
of activated neutrophils in the Hemorrhage group (24.568.2
counts/field) was significantly higher than in the Sham group
(3.460.5 counts/field) at 5 hours after hemorrhage (Fig. 8C). In
contrast, the number of activated neutrophils in the FR+
Hemorrhage group (8.262.8 counts/field) was not significantly
higher than in the Sham group and was significantly lower than
that of the Hemorrhage group at 5 hours (Fig. 8C).
Discussion
Several investigators have studied the role of p38 MAPK
activation on liver damage following ischemia/reperfusion, dermal
burns, and hemorrhage with resuscitation [4,5,21,22]. However,
Figure 5. Changes in hepatic TNF-a expression after hemor-
rhage. TNF-a mRNA was assessed by RT-PCR. Relative TNF-a mRNA
expression levels, shown on the vertical axis in B, were expressed after
normalization with GAPDH. The Hemorrhage group showed the
greatest increase in TNF-a expression at 1 hour post-hemorrhage, and
the levels were higher than in the Sham group for up to 5 hours. On the
contrary, the TNF-a mRNA level in the FR+Hemorrhage group did not
change significantly from the baseline value. The serum TNF-a level in
the Hemorrhage group was significantly higher than baseline value at 1
hour after a hemorrhage and decreased subsequently, but was
significantly higher than the Sham group at all timepoints post-
hemorrhage, as shown in C. In contrast, the serum TNF-a level in the
FR+Hemorrhage group did not show an increase from baseline
throughout the experiment. Data are shown as mean6SE. n=5/groups,
*p ,0.05 vs Sham, + p,0.05 between Hemorrhage and FR+Hemor-
rhage.
doi:10.1371/journal.pone.0030124.g005
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relationship between liver damage and p38 MAPK activation
using pharmacological inhibitors. In this study, we tried to take a
more comprehensive approach to analyzing the precise role of p38
MAPK activation in liver damage by identifying related factors
associated with the pathological sequence of events, such as blood
flow in the hepatic artery, p38 MAPK activation, the activation of
pro-inflammatory cytokines, and neutrophil accumulation. The
p38 MAPKs are reported to be activated by severe cellular stress
such as that due to reactive oxygen species generated from
ischemia and reperfusion [4,23], which are involved in prolifer-
ation, differentiation and production of proinflammatory cytokines
including TNF-a and IL-1b [7].
Ischemia and/or ischemia-reperfusion is a consequence of
the hemodynamic changes that follow hemorrhagic shock
[10,11,12,13]. The liver is supplied with approximately 30% of
the total cardiac output, 20% of which goes through the hepatic
artery and 80% through the portal vein [24,25]. Both avenues of
blood flow depend significantly on the systemic arterial blood
pressure [24]. However, once hepatic blood flow decreases
following hemorrhagic shock, hypovolemia triggers a corrective
response that includes lowering of the resistance in the hepatic
artery and the release of endogenous vasodilating substances such
as prostaglandins, adenosine, and glucagon [24]. The average
oxygen saturation in the portal vein was 74.5% [26], which was
significantly lower than that in the hepatic artery [26]. Therefore,
we measured blood flow in the hepatic artery in the present study
to determine the degree of hepatic ischemia. Hepatic arterial
blood flow decreased to approximately 40% of the pre-bleeding
level immediately after hemorrhage and temporarily recovered in
proportion to the change in systemic arterial pressure (Fig. 1, 2).
These results revealed that hemorrhaging of up to 25% of the total
blood volume caused an immediate significant ischemic state in
the liver. We presumed that the present hepatic ischemia resulting
from the decrease in systemic arterial pressure was a primary cause
Figure 6. Changes in hepatic IL-1b mRNA expression after
hemorrhage. The IL-1b mRNA level in the Hemorrhage group was
highest at 3 hours post-hemorrhage, and was higher than that of the
Sham group at all timepoints. On the contrary, the IL-1b mRNA level in
the FR+Hemorrhage group showed no change from baseline at any
timepoint after hemorrhage. Similarly, the serum IL-1b level in the
Hemorrhage group was significantly increased from baseline at 3 hours
after hemorrhage and then decreased over time, but was significantly
higher than in the Sham group at all the timepoints post-hemorrhage
as shown in C. In contrast, the serum IL-1b level in the FR+Hemorrhage
group showed no change from the baseline value throughout the
experiment. Data are shown as mean6SE. n=5/groups, * p,0.05 vs
Sham, + p,0.05 between Hemorrhage and FR+Hemorrhage.
doi:10.1371/journal.pone.0030124.g006
Figure 7. Changes in serum AST and ALT levels. The levels of liver
enzymes in the Hemorrhage group increased with time and were
significantly higher than in the Sham group at 5 hours after
hemorrhage. Administration of FR167653 (FR+Hemorrhage group)
inhibited the increase AST and ALT (A and B respectively). Data are
shown as mean6SE. n=5/groups, * p,0.05 vs Sham, + p,0.05
between Hemorrhage and FR+Hemorrhage.
doi:10.1371/journal.pone.0030124.g007
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(Fig. 4).
Bacterial LPS derived from the gut has also been reported to
play an important role in the progression of liver damage through
the activation of the p38 MAPK pathway [27]. Jiang et al.
suggested that decreased blood flow after hemorrhaging induces
intestinal barrier damage followed by the development of bacterial
translocation, and demonstrated that plasma bacterial LPS in the
portal vein increased at 90 minutes, peaked at 150 minutes and
decreased subsequently [28]. In the present study, we measured
the plasma concentration of bacterial LPS in the portal vein and
although a slight increase was observed in the hemorrhage group,
the elevation was not statistically significant (Fig. 3). p38 MAPK
was not activated significantly at 3 hours post- hemorrhage (Fig. 4),
the time at which the bacterial LPS level had been reported by
others to be highest in the portal vein. We concluded that bacterial
LPS had little effect on the activation of p38 MAPK in the liver
following hemorrhagic shock in our model.
TNF-a and IL-1b in the liver are synthesized mainly by Kupffer
cells through the activation of p38MAPK [10,21,29,30]. The
expression of TNF-a mRNA and the serum levels of TNF-a
peaked at 1 hour post-hemorrhage (Fig. 5), and the expression of
IL-1b mRNA and the serum levels of IL-1b peaked at 3 hours
(Fig. 6). The temporal pattern of these responses was similar to that
in our previous study on renal and cardiac expression of the
cytokines after hemorrhagic shock [12,13]. The peak of p38
MAPK activation was not very robust in comparison with the peak
for other pro-inflammatory cytokines. Kobayashi et al. reported
that p38 MAPK was significantly activated up to 30 minutes after
the induction of reperfusion [4]. Activation of p38 MAPK might
have occurred to a greater extent at timepoints earlier than 1 hour
after hemorrhage. TNF-a and IL-1b are important factors in the
induction of leukocyte chemotaxis in conjunction with adhesion
molecules such as b4 integrin, ICAM-1, b2 integrin, and VCAM-1,
which are involved in nutrophil adhesion to the surface of hepatic
vascular endothelial cells and neutrophil infiltration in the liver
[5,31,32]. In this study, neutrophils increased in the liver in the
hemorrhage group at 5 hours after hemorrhage (Fig. 8). Adherent
neutrophils are known to generate and release numerous active
substances, such as proteolytic enzymes and reactive oxygen
species [8,9,10], and also known to contribute to hepatocyte
damage by forming sinusoidal plugs [9,32]. Activated Kupffer cells
also cause hepatocyte damage by releasing reactive oxygen and
nitrogen species [10]. All of the above-mentioned factors have the
potential to damage both the endothelial layer and adjacent tissue
directly or indirectly in the liver. In the present experiments,
hepatocyte damage was evaluated based on the serum concentra-
tions of AST and ALT in the late phase after hemorrhagic shock
(Fig. 7). FR167653 suppressed inflammation-related liver damage
by suppressing p38 MAPK activation. These results demonstrate
that activation of p38 MAPK by hepatic ischemia played a key
role in the liver dysfunction that occurred as a result of the
inflammatory response induced by hemorrhagic shock.
In the case of long term hepatic ischemia followed by
reperfusion, p38 MAPK activation enhanced the liver damage
via induction of the above-mentioned inflammatory process. On
Figure 8. Light micrograph showing the liver at 5 hours post-
hemorrhage. The interstitial space was edematous and the sinusoidal
capillaries were dilated with diffuse congestion. Some neutrophils,
which have the appearance of reddish brown precipitates, were present
in the sinusoidal cavity and interstitial space in the Hemorrhage group
(A). These histological changes were not observed in the FR+Hemor-
rhage group (B). Bar=100 mm. Number of activated neutrophils in the
liver (500 mm
2) as shown in C. In the Hemorrhage group, activated
neutrophils were significantly increased at 5 hours, but markedly
reduced in the group treated with FR167653 (FR+Hemorrhage) at
5 hours post-hemorrhage. Data are shown as mean6SE. n=5/groups,
*p ,0.05 vs Sham, + p,0.05 between Hemorrhage andFR+Hemorrhage.
doi:10.1371/journal.pone.0030124.g008
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e30124the contrary, p38 MAPK activated as a result of a brief period of
ischemia followed by reperfusion was reported to prevent the
progression of liver damage induced by a subsequent extended
period of ischemia followed by reperfusion, a paradigm referred to
as ischemic preconditioning [33,34]. The present model involved a
single 20-minute-bleeding followed by reperfusion in the liver. We
could not confirm the efficacy of the preconditioning in this study,
and thus the possibility remains that ischemic preconditioning
could protect against liver damage following repetitive hemor-
rhagic shock.
Takahashi et al. reported that FR167653 inhibited p38a MAPK
activation selectively [18]. p38a MAPK is highly expressed in
leukocytes and endothelial cells, which are readily affected by the
decrease of blood flow following hemorrhagic shock. We reasoned
that p38a MAPK activation might play a pivotal role in the
present liver damage model, though we did not confirm the
isoform of p38 MAPK in this study.
In conclusion, the present data indicates that activation of p38
MAPK is essential for the progression of inflammatory hepatic
damage following hemorrhagic shock. Thus, inhibition of p38
MAPK activation at an early phase after hemorrhage could be an
effective means of preventing the development of liver damage and
multiple organ failure following hemorrhagic shock.
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